We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current WVE market cap is 1.94B. The company's latest EPS is USD -0.3771 and P/E is -34.77.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 49.39M | 29.64M | 12.9M | 19.67M | -7.34M |
| Operating Income | 4.62M | -18.1M | -34.09M | -35.02M | -63.58M |
| Net Income | 7.25M | -16.26M | -31.56M | -32.92M | -61.78M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 15.98M | 20.08M | 40.96M | 3.66M | 115.18M |
| Operating Income | -198.58M | -151.32M | -122.48M | -162.71M | -66.12M |
| Net Income | -193.64M | -149.91M | -122.25M | -161.82M | -57.51M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 199.92M | 274.95M | 235.27M | 208.82M | 358.5M |
| Total Liabilities | 240.4M | 235.32M | 209.88M | 212.3M | 216.86M |
| Total Equity | -40.49M | 39.63M | 25.39M | -3.48M | 141.64M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 284.25M | 279.24M | 207.01M | 146.39M | 274.95M |
| Total Liabilities | 212.64M | 188.59M | 174.51M | 191.48M | 235.32M |
| Total Equity | 71.61M | 90.65M | 32.5M | -45.09M | 39.63M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 13.81M | -19.43M | -33.43M | -60.9M | -107.38M |
| Investing | -759k | -1.12M | -417k | -469k | -852k |
| Financing | 38.57M | 132.53M | 14.51M | 15.16M | 218.91M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -188.23M | -115.98M | -88.99M | -127.78M | -19.43M |
| Investing | -3.92M | -1.34M | -560k | -1.26M | -1.12M |
| Financing | 164.4M | 154.54M | 55.83M | 67.19M | 132.53M |
| Market Cap | 1.94B |
| Price to Earnings Ratio | -34.77 |
| Price to Sales Ratio | 17.36 |
| Price to Cash Ratio | 9.98 |
| Price to Book Ratio | 50.46 |
| Dividend Yield | - |
| Shares Outstanding | 152.52M |
| Average Volume (1 week) | 1.74M |
| Average Volume (1 Month) | 1.18M |
| 52 Week Change | 159.00% |
| 52 Week High | 16.735 |
| 52 Week Low | 3.50 |
| Spread (Intraday) | 1.11 (8.04%) |
| Company Name | Wave Life Sciences Ltd |
| Address |
8 cross street #10-00����� singapore 018936 |
| Website | https://www.wavelifesciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
